Vitry-sur-Seine, France

Alain Commerçon


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 28(Granted Patents)


Location History:

  • Vitry-sur-Seine, FR (2011 - 2012)
  • Paris, FR (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alain Commerçon

Introduction

Alain Commerçon is a notable inventor based in Vitry-sur-Seine, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of five patents to his name, Commerçon has focused on developing novel therapeutic agents.

Latest Patents

One of his latest patents is titled "Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use." This invention relates to novel tomaymicine derivatives that include a linker. It also encompasses conjugate molecules that consist of one or more of these tomaymicine derivatives covalently linked to a cell binding agent through a linking group present on the linker of the tomaymycin derivative. Another significant patent is "Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof." This invention pertains to dimers of artemisinin derivatives, detailing processes for their preparation, methods of treatment involving their administration, and intermediates for such dimers.

Career Highlights

Throughout his career, Alain Commerçon has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Commerçon has collaborated with notable colleagues such as Jidong Zhang and Yannick Benedetti. These partnerships have likely enhanced the scope and impact of his research and inventions.

Conclusion

Alain Commerçon's innovative work in developing new therapeutic agents showcases his significant contributions to the pharmaceutical field. His patents reflect a commitment to advancing medical science and improving treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…